Journal Article Summary
The article investigates the issue of aspirin resistance in patients with chronic coronary artery disease, particularly focusing on the role of patient compliance in this phenomenon. Aspirin is commonly prescribed to help prevent adverse cardiovascular events, especially in individuals with a history of myocardial infarction. However, some patients appear to be resistant to its effects, which has raised concerns about the effectiveness of aspirin therapy and the potential for increased cardiovascular risks in non-compliant patients.
The study involved 230 participants, including patients with a history of myocardial infarction and healthy controls, who were monitored for their compliance with aspirin intake. Researchers measured platelet function before and after aspirin ingestion to assess the degree of inhibition caused by the medication. The findings revealed that a significant portion of those previously labeled as aspirin resistant were actually non-compliant with their medication regimen. Specifically, only 3% of compliant patients showed a decreased response to aspirin, while 93% of those with aberrant platelet responses were due to non-compliance.
Despite its valuable insights, the study has limitations, including a relatively small sample size and the potential for other factors influencing platelet response that were not fully explored. Patients should be aware that non-compliance with prescribed medications can lead to serious health risks, and it is crucial to discuss any concerns about medication adherence with a healthcare professional. Understanding the reasons behind aspirin resistance can help tailor treatment plans and improve patient outcomes in managing coronary artery disease.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Schwartz Kenneth A, Schwartz Dianne E, Barber Kimberly, Reeves Mathew, De Franco Anthony C. Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients. Journal of Translational Medicine 2008. DOI: 10.1186/1479-5876-6-46. PMID: 18759978. PMCID: PMC2538501.
Featured Pill Pals Product
OTC 1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
